The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von ZhangXing Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Success Hospital Affiliated to Xiamen University, Xiamen, Fujian 361000, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is classified as a cancer with high metastasis so that its mortality rate is high and most of the patients could not survive longer than 5 years. RAS signaling participate in cellular processes, so it has a key role in PDAC.RAS activation is associated via three different signaling pathway including somatic oncogenic point mutations in KRAS, upstream signaling like EGFR, oncogenic activation of the downstream B-RAF molecule. Several targeted therapies have been developed against kinase effectors particularly those in the MAPK and PI3K (phosphoinositide 3-kinase)/mTOR signaling pathways and several inhibitors are undergoing clinical studies at the moment. However, because it is highly metastatic and frequently diagnosed at advanced disease stages, pancreatic cancer continues to be a challenging cancer to treat. This article will explore therapeutic approaches that focus on oncogenic KRAS signaling in pancreatic cancer and provide an updated synopsis of our knowledge of how mutant KRAS function in the illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Success Hospital Affiliated to Xiamen University, Xiamen, Fujian 361000, China.
- Department of Gastroenterology, Success Hospital Affiliated to Xiamen University, Xiamen, Fujian 361000, China. Electronic address: cmy2662@163.com.
Zitieren
APA
Chen, Z., Chen, M., Fu, Y., & Zhang, J. (2023). The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154603
Vancouver
Chen Z, Chen M, Fu Y, Zhang J. The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154603
BibTeX
@article{Chen2023,
author = {Chen, ZhangXing and Chen, Meiyan and Fu, Yuka and Zhang, Jingyi},
title = {The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154603}
}
EUVIMED